- ACTIVE STOCK TRADERS: Get full access to Jim Cramer's thoughts for less than $3/week - sometimes before he says them on TV! Start with a 14-Day Free Trial.
Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model. NEW YORK ( TheStreet) -- Quest Diagnostics (NYSE: DGX) hit a new 52-week high Wednesday as it is currently trading at $63.99, above its previous 52-week high of $63.98 with 90,547 shares traded as of 11:20 a.m. ET. Average volume has been 848,200 shares over the past 30 days. Quest has a market cap of $10.06 billion and is part of the health care sector and health services industry. Shares are up 9.6% year to date as of the close of trading on Tuesday. Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company has a P/E ratio of 14.6, equal to the average health services industry P/E ratio and below the S&P 500 P/E ratio of 17.7.